ABG
NAUT icon

Ally Bridge Group’s Nautilus Biotechnolgy NAUT Stock Holding History

Ally Bridge Group’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-159,232
Closed -$287K – 30
2022
Q4 		$287K Sell
159,232
-664,742
-81% -$1.28M 0.28% 28
2022
Q3 		$1.75M Sell
823,974
-256,592
-24% -$645K 1.15% 28
2022
Q2 		$2.91M Hold
1,080,566
– – 2.65% 19
2022
Q1 		$4.69M Sell
1,080,566
-144,494
-12% -$593K 3.48% 13
2021
Q4 		$6.35M Sell
1,225,060
-274,940
-18% -$1.47M 2.22% 20
2021
Q3 		$9.21M Hold
1,500,000
– – 2.71% 16
2021
Q2 		$15.2M Buy
+1,500,000
New +$16.2M 3.76% 13

Other funds holding NAUT

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return

Ally Bridge Group's NAUT Position: Q1 2023 in Review

Ally Bridge Group sold out of Nautilus Biotechnolgy (NAUT) in Q1 2023, closing a stake of 159,232 shares — an estimated $287K sold.

Ally Bridge Group first reported a position in NAUT in Q2 2021 and held it in 7 quarters. The position peaked at $15.2M in Q2 2021. 73 funds tracked by Wall St. Rank hold NAUT as of Q1 2023.

  • Ally Bridge Group reported no remaining Nautilus Biotechnolgy position as of Q1 2023 after selling out during the quarter.
  • Ally Bridge Group sold 159,232 Nautilus Biotechnolgy shares in Q1 2023, an estimated $287K.
  • Ally Bridge Group first reported a position in Nautilus Biotechnolgy in Q2 2021 and held it in 7 quarters.
  • Ally Bridge Group's Nautilus Biotechnolgy position peaked at $15.2M in Q2 2021.
  • 73 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2023.

Based on Ally Bridge Group's 13F filing for Q1 2023, filed 15 May 2023.